Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 19/20 | 0.59 |
| ▸ | NR3C2 | P08235 | 13/20 | 0.59 |
| ▸ | PGR | P06401 | 8/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4039578 | 0.91 | NR3C1 (0.71) | NR3C1NR3C2PGR | |
| SCHEMBL4138205 | 0.84 | NR3C1 (0.61) | NR3C1NR3C2PGR | |
| SCHEMBL27774909 | 0.83 | NR3C1 (0.54) | NR3C1NR3C2PGR | |
| SCHEMBL4122397 | 0.83 | NR3C1 (0.51) | NR3C1NR3C2PGR | |
| SCHEMBL3657951 | 0.83 | NR3C1 (0.59) | NR3C1NR3C2PGR | |
| SCHEMBL3656612 | 0.82 | NR3C1 (0.72) | NR3C1NR3C2PGR | |
| SCHEMBL4128075 | 0.81 | NR3C1 (0.46) | NR3C1NR3C2PGR | |
| SCHEMBL4142575 | 0.81 | NR3C1 (0.72) | NR3C1NR3C2PGR | |
| SCHEMBL4120626 | 0.81 | NR3C1 (0.72) | NR3C1NR3C2PGR | |
| SCHEMBL4138451 | 0.81 | NR3C1 (0.58) | NR3C1NR3C2PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2049112-A2 | TREATING INFECTIONS AND SEQUELAE THEREOF WITH COMBINED DISSOCIATED GLUCOCORTICOID RECEPTOR AGONISTS AND ANTI-INFECTIVE AGENTS | Bausch & Lomb Incorporated (US) | 2009-04-22 | — | — | EP | disclosed |
| WO-2008021728-A2 | TREATING INFECTIONS AND SEQUELAE THEREOF WITH COMBINED DISSOCIATED' GLUCOCORTICOID RECEPTOR AGONISTS AND ANTI-INFECTIVE AGENTS | BAUSCH & LOMB INCORPORATED (US) | 2008-02-21 | — | — | WO | disclosed |